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Recently,  the  ability  of polymeric  collagen-like  peptides  to  regulate  cell behavior  has  generated  great
interest.  A  triple-helical  peptide  known  as  collagen-related  peptide  (CRP)  contains  the  sequence  (Gly-
Pro-Hyp)10.  With  Gly-Pro-Cys  triplets  appended  to  both  of  its termini,  designated  CRPcys, chemical
cross-linking  using  heterobifunctional  reagents  generates  CRPcys-XL, a potent,  widely  used,  polymeric
agonist  for  platelet  Glycoprotein  VI,  whereas  non-cross-linked,  monomeric  CRPcys antagonizes  Glycopro-
tein VI. Here,  we  describe  how  cysteine  in  these  triplets  may  also  undergo  random  air-induced  oxidation,
especially  upon  prolonged  storage  or  repeated  freeze–thawing,  to form  disulphide  bonds,  resulting  in  aelix
iber
ysteine
olymer
xidation
lesser  degree  of  polymerization  than  with  chemical  cross-linking.  We  investigated  the  monomeric  and
polymeric  states  of these  and  other  cysteine-containing  collagen-derived  peptides,  using  gel ﬁltration
and  dynamic  light  scattering,  allowing  the  size  of  a CRP-XL  aggregate  to  be  estimated.  The  effect  of  cys-
teine thiols  upon  peptide  adsorption  to  surfaces  and  subsequent  platelet  responses  was investigated.
This  demonstrated  that  cysteine  is required  for strong  binding  to glass  coverslips  and  to  plastic  platesross-link
dhesion
used  in  ELISA  assays.
. Introduction
Collagens are characterized by the triple-helical structure
esulting from the presence of repeating GXX’ triplets, where G is
lycine, X is commonly proline (P), and X′ is commonly hydroxypro-
ine (O). The ﬁbrillar collagens I and II, whose main triple-helical
omains comprise 338 such triplets, are the fundamental scaffolds
f the extracellular matrix in bone, tendon (type I), and carti-
age (type II) [4,7]. In blood vessel walls and skin, collagen I is
nterlaced with collagen III, having a 343-triplet helix, whereas
on-ﬁbrillar collagen IV networks form basal laminae in struc-
ures such as kidney glomeruli, lung alveoli, and blood vessel walls
19]. These collagens, along with the 24 other known collagen
ypes, are widely distributed. Accordingly, a large repertoire of pro-
eins bind to the collagens, including structural components of the
xtracellular matrix as well as cell receptors that mediate physi-
logical processes such as cell migration, hemostasis, and wound
ealing.
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In 1995, Barnes developed a platelet-reactive model peptide,
a GPO polymer now called collagen-related peptide (CRP) [18]
which proved to bind the immune receptors, platelet Glycoprotein
VI (GpVI) [10,29] and leukocyte-associated immunoglobulin-
like receptor-1 (LAIR-1) [14]. Its variant, CRPcys (Table 1) may
be chemically cross-linked between its N-terminal amines and
cysteine thiols to form soluble aggregates (CRPcys-XL) using 3-(2-
pyridyldithio)propionic acid N-hydroxy-succinimide ester (SPDP).
When CRPcys-XL binds GpVI, platelets are activated, leading to their
aggregation [11,18].
Subsequently, a small set of triple-helical peptides containing
primary sequence from collagen I was used to identify GFOGER as
a motif that binds integrins 11 and 21 [12]. To cater for the
possibility that cross-linking may  similarly be required to support
cellular activation via clustering of integrins, these and subsequent
peptides, such as GFOGERcys (Table 1), generally included termi-
nal Cys residues. We  then synthesized two large sets of peptides
(Toolkits) encompassing the entire triple-helical domains of the
homotrimeric collagens II and III in 56 and 57 peptides, respec-
tively [3,14].  We  use three examples of Toolkit peptides in this
paper (Table 1). With the aid of their helix-inducing host sequence,
Open access under CC BY-NC-ND license.all these peptides fold to form canonical collagen triple helices of
similar stability to native collagen [23]. Toolkit peptides have facil-
itated the systematic mapping of receptors [3,14,33] and structural
binding proteins [3,15,16] onto collagens II and III.
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Fig. 1. Peptide complexes that result from cysteine oxidation. Reduced peptide
monomers (black line) may  become cyclic (black circle), or cross-link with other pep-
tides to form open (pink) and cyclic (red) dimers, open (light blue) and cyclic (dark
blue) trimers, or even larger open (brown) and cyclic (green) peptide multimers.
Many of these forms can then combine to form triple helices with other pep-
tide monomers or complexes. These complexes may  involve parallel triple helices
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Applications for triple-helical peptides may  be developed in
everal ways: the Toolkit approach might be applied to collagen
 using heterotrimeric peptides [5,25,28]. Collagen-mimetic pep-
ides are used in biomaterials [24] and may  also have diagnostic
pplications. For example, the identiﬁcation of a site that bound von
illebrand factor (VWF) using the Toolkits [16] enabled the devel-
pment of a deﬁned, collagen-mimetic peptide mixture of VWF-,
pVI- and integrin-binding peptides that can support thrombus
ormation under shear conditions [22], valuable for diagnostic pur-
oses. Although the heterogeneity of these peptides is increased
y random oxidation of their terminal cysteine residues (Fig. 1),
he latter provide a valuable means of introducing higher-order
tructure through chemical crosslinking. Their role has not been
nvestigated in any depth, and forms an important focus of this
eport.
Here, we provide a framework for investigating cross-linked
olymeric collagen peptides that complements work on ﬁbril-
orming collagen peptides where cysteine aids helix stabilization
13,21]. We  also investigate the enhancement of adhesive prop-
rties conferred by the oxidation of cysteine upon storage, where
he main use of peptides is to investigate cell–collagen interaction
sing solid-phase adhesion methodology.able 1
eptides used in this study.
Peptide Sequence (-amide blocked) Mass (Da) Tmax
GFOGER (GPP)9GFOGER(GPP)9G 5257 nd
GFOGERcys GPC(GPP)5GFOGER(GPP)5GPC 3704 45
B-GFOGER B-G-3Abu-G(GPP)5GFOGER(GPP)5G 3672 nd
B-GFOGERcys B-GPC(GPP)5GFOGER(GPP)5GPC 3930 nd
CRP (GPO)10G 2747 69
CRPcys GCO(GPO)10GCOG 3294 72
B-CRP B-G-4Abu-G(GPO)10G 3172 nd
GPPcys GPC(GPP)10GPCG 3100 48
B-GPP B-G-3Abu-G(GPP)10G 3012 44
II-56 §-GPRGRSGETGPAGPOGNOGPOGPOGPO-§ 5521 59
III-04 §-GPSGPAGKDGESGROGROGERGLOGPO-§ 5634 53
III-24 §-GPKGNDGAOGKNGERGGOGGOGPQGPO-§ 5500 51
bu, aminobutyric acid; B, biotin; §, the last three are Toolkit peptides ﬂanked by
he host sequences: GPC(GPP)5 (N-terminus) and (GPP)5GPC (C-terminus); Tmax,
elix-unfolding temperature (◦C); nd, not done.s 36 (2012) 86–93 87
2. Materials and methods
2.1. Peptide synthesis
Peptides were synthesized as C-terminal amides on Tent-
aGel R-Ram resin using an Applied Biosystems Pioneer peptide
synthesizer as described previously [23]. Fractions containing
homogeneous product were identiﬁed by analytical HPLC on
an ACEphenyl300 (5 m)  column, characterized by MALDI and
electrospray mass spectrometry, pooled and freeze-dried. Where
applicable, biotin was  coupled to the N-terminal group by addition
of N-(biotinyloxy)succinimide (5 equiv.) to the peptide resin prior
to cleavage. Biotinylation of peptides was found to be effectively
100%. Peptides, listed in Table 1, were checked for helicity [23].
2.2. Peptide oxidation during storage
Samples of Toolkit peptide III-24 and CRPcys were dissolved at
2.5 mg  mL−1 in cold 10 mM acetic acid. Peptides were held at 4 ◦C
for 2 h, 1 d, 3 d, 14 d, or frozen (−20 ◦C) for 2 h, 1 d, 3 d, 14 d, or
80 d before immediate gel ﬁltration analysis; a ﬁnal sample was
frozen for 14 d but thawed ten times during that period, mim-
icking sequential sampling. The experiment was repeated, except
that nitrogen was bubbled through the acetic acid for 2 min before
using it to dissolve peptide. As peptides are normally stored at 4 ◦C,
we also retrieved 9–48-month-old stock samples of CRPcys, GPPcys,
GFOGERcys, II-56, III-04 and III-24, all kept at 1 mg  mL−1 in 10 mM
acetic acid. Samples were analyzed using mass-spectrometry, gel
ﬁltration, and reduced cysteine quantiﬁed using Ellman’s reagent,
5,5′-dithio-bis(2-nitrobenzoic acid) (Sigma D8130) [2].
2.3. Synthesis of CRPcys-XL
The heterobifunctional reagent SPDP (Sigma P3415) was
dissolved in dry ethanol (50 mM),  added to 3 mM peptide pre-
dissolved in 0.1 M NaHCO3 (1.5 equiv.), and the mixture ﬂushed
with N2 gas. After 1 h, peptide was dialyzed overnight at 4 ◦C in
0.01 M acetic acid (one change), stored at 4 ◦C or freeze-dried and
stored at −80 ◦C.
2.4. Dynamic light scattering (DLS)
Peptide III-24 (2.5 mg  mL−1) was dissolved in 10 mM phosphate-
buffered saline pH 7.4 containing 2 mM TCEP, heated brieﬂy to 70 ◦C
and allowed to fold for 18 h overnight at 4 ◦C. It was  ﬁltered and
loaded into a DynaPro Titan DLS instrument pre-equilibrated at
4 ◦C. The sample was  probed at 4–50 ◦C, being equilibrated at each
temperature for 5 min. Data was  handled as previously described
[17] and the hydrodynamic radius in nm used to calculate a pre-
dicted molecular weight as appropriate for different polymers: a
rod-like triple helix, an aggregate of triple helices, or a denatured
single chain. We  did not observe any collagenous gel formation.
2.5. Gel ﬁltration of peptide
Peptide cross-linking and helicity was measured by prepar-
ing 800 L samples at 0.25 mg  mL−1 in 10 mM phosphate buffered
saline (pH 7.4) and loading onto a Bio-sep Sec-S2000 Gel ﬁltration
column (300 mm  × 21.2 mm,  5 M bead size, 14.5 nm average pore
size) at 10 ◦C, equilibrated in the same buffer. Running isocratically,
the eluant was monitored at 214 nm.  For peptide III-24, the column
was additionally run at 40 ◦C to investigate the increased stability
conferred by cross-linking, and peptide III-24, III-04, GPPcys, and
GFOGERcys, were additionally sampled at 60 ◦C to obtain a peptide
polymer proﬁle (Suppl. Table S1b).
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Fig. 2. Modeled gel ﬁltration peaks. Eluted peaks from molecules of Stokes Radius
7, 4, 2, 1, and 0.5 nm are modeled for a Bio-sep Sec-S2000 column (average pore
size  = 14.5 nm), larger molecules eluting ﬁrst. (a) Effect of variable pore sizes within
the column beads of 14.5 ± 0.5 nm (sharp peaks), 14.5 ± 1 nm,  and 14.5 ±2 nm (broad
peaks), with no peak broadening due to axial dispersion. (b) Effect of an axial dis-
persion coefﬁcient (L) of 0.5 cm2 h−1 (sharp peaks), 1 cm2 h−1, and 2 cm2 h−1 (broad
peaks) with no peak broadening due to variable pore sizes. (c) Combining both
effects, we show elution from a virtual column with pore sizes of 14.5 ± 1.5 nm with
an  axial dispersion coefﬁcient of 0.5 cm2 h−1 (sharp peaks), 1 cm2 h−1 (average), and
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Fig. 3. Gel ﬁltration of three CRPcys-XL preparations. (a) A very active CRPcys-XL
preparation typically used for platelet aggregation studies, effective at <15 ng mL−1.
(b  and c) Less active preparations, requiring 30 ng mL−1 (b) or 120 ng mL−1 (c) for a
similar effect (see Suppl. Fig. S1).
m:  monomer – Stokes’ Radius (R) = 1.3 nm;  H: 1 triple helix, R = 2.3 nm;  2H: 2 triple cm2 h−1 (broad peaks).
Overlapping gel ﬁltration sample peaks derived from different
eptide polymers require mathematical deconvolution into com-
onents. Three major effects describe a gel ﬁltration peak: ﬁrst,
ead pore size and homogeneity (r ± , Fig. 2a, Suppl. Section 2.10);
econd, diffusion and inhomogeneity of ﬂow, using the axial dis-
ersion coefﬁcient, L (Fig. 2b and Suppl. Section 2.11); third, solute
nteractions. To reduce the dimensionality of the model, we allowed
n increase in L to include solute interactions (Suppl. Section 2.12).
e combined these effects by allowing  and L to vary, modeled
n Fig. 2c, and ﬁtted multiple peaks to each dataset (Suppl. Section
.13).
Overlapping peaks in our results could represent TCEP; non-
elical peptide; N- to C-terminal cyclic cross-linked non-helical
eptide monomer; cross-linked non-helical peptide dimers; cross-
inked cyclic dimeric peptide; peptide triple helix; cross-linked
riple helix dimers; small groups of (∼3–5) cross-linked triple
elices; and larger groups of (6+) cross-linked triple helices. The
ast four classes are heterogeneous and could not be fully resolved,
o it was decided to ﬁt a peak representing a variety of molecule
izes, for instance, grouping all 3–5 helix aggregates under one ﬁt-
ed peak. The deconvolution was used to present data giving the
ercentages of peptide in each peptide form (Figs. 3–5).helices, R =3.5 nm;  4H: ∼3–5 triple helices, R = 5.1 nm;  A: aggregate (up to 80 triple
helices), R = 8.6 nm.
2.6. Mass spectrometry of products
Peptide samples were desalted by adsorbing to a preconditioned
C18 Ziptip (Millipore). For electrospray, they were eluted with
70% MeOH/0.2% formic acid, and delivered to the mass spectrom-
eter by direct infusion at 4 L min−1 using 70% MeOH/0.2% formic
acid as mobile phase, with a capillary temperature of 80 ◦C. Internal
calibration data was  also collected using either ubiquitin or myo-
globin. For MALDI (Waters MicroMX), they were washed with 0.1%
triﬂuoroacetic acid and eluted with matrix solution, mixed with
ferulic acid matrix (10 mg  mL−1 in 50% acetonitrile, 0.1% triﬂuo-
roacetic acid), dried and washed with 0.1% triﬂuoroacetic acid. To
conﬁrm the redox state of peptide samples and a TCEP-reduced
negative control, peptides were alkylated using 120 mM iodoac-
etamide (Sigma I6125), pH 8, for 30 min  at room temperature before
analysis [31].
2.7. Whole blood perfusion experiments
Blood from healthy volunteers was  collected into 40 M d-phe-
pro-arg-chloromethylketone (PPACK, Cambridge Bioscience, UK),
and supplemented hourly with 10 M PPACK. It was  incubated with
1 M 3,3′-dihexyloxacarbocyanine iodide (DIOC6, Sigma–Aldrich,
UK) for 15 min  before use. Acid-cleaned coverslips (Menzel-Glazer,
Germany) were washed in a solution of 1 M HCl in 50% ethanol,
followed by two washes with 300 mM NaCl and a ﬁnal wash with
water. Base-treated coverslips were washed ﬁnally with 1 M NaOH.
These coverslips were incubated with a mixture of two peptides
(100 g mL−1 each) in a humidity chamber overnight. The peptide
mixture was either CRPcys and GFOGERcys or the cysteine-lacking
CRP and GFOGER (Table 1). After removal of excess ﬂuid, coverslips
were blocked with 1% BSA in HEPES buffer (36 mM NaCl, 2.7 mM
KCl, 5 mM HEPES, 10 mM glucose, 2 mM MgCl2, 2 mM CaCl2, pH
7.4) for 15 min. Individual coverslips were loaded into a 125 m
deep ﬂow chamber mounted on an FV300 laser-scanning confo-
cal microscope (Olympus, UK) and washed for 1 min  with HEPES
buffer. Blood was drawn through the chamber using a syringe pump
−1for 5 min  at a shear rate of 1000 s [22]. Following each experi-
ment, the chamber was  ﬂushed using HEPES buffer before image
acquisition.
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Fig. 4. Gel ﬁltration of CRPcys: (a) freshly dissolved; (b) 14d, 4 ◦C; (c) 9 month, 4 ◦C;
(d)  53 month, 4 ◦C; (e) freeze–thawed 10× during 14 d, −20 ◦C. Peptide percentages
are given for:
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Fig. 5. Gel ﬁltration of III-24. (a) Sample TCEP-reduced after 18 h at 4 ◦C; (b) 2 h at
4 ◦C; (c) 14 d at 4 ◦C (14 d at −20 ◦C is similar). (d) After freeze thawing 10× during
a  14 d period at −20 ◦C; (e) 80 d at −20 ◦C; (f) 37 month at 4 ◦C.:  monomer – Stokes’ Radius (R) = 1.0 nm;  H: 1 triple helix, R = 1.8 nm;  2H: 2 triple
elices, R = 2.9 nm;  4H: ∼3–5 triple helices, R = 3.5 nm;  A: small aggregate, R = 4.5 nm;
:  solvent (right-most peak).
.8. Adhesion assays
Platelet adhesion was measured by detecting phosphatase
eleased by lyzing adherent platelets [20]. Peptide solutions
100 L; 10 g mL−1 in 0.01 M acetic acid) were added to 96-well
lates and left overnight at 4 ◦C. Excess ligand was  discarded and
ells were blocked with 175 L 5% bovine serum albumin (BSA)
n calcium-free Tyrodes’ buffer (CFT) for 1 h, after which the wells
ere washed 3 times with 175 L 0.1% BSA in CFT. Washed mouse
latelets (50 L; 1.25 × 108 mL−1) from wild-type or FcR-chain
nockout animals which lack functional GpVI [6] were incubated
n each well at room temperature for 1 h. Excess, non-bound
latelets were discarded and the wells were washed 3 times. Citrate
ysis buffer (150 L: 3.53 mM p-nitrophenyl phosphate, 71.4 mM
risodium citrate, 28.6 mM citric acid, 0.1% (v/v) Triton X-100; pH
.4) was added to each well for 1 h at room temperature. Then,m:  monomer – Stokes’ Radius (R) = 1.3 nm;  H: 1 triple helix, R = 1.9 nm; 2H: 2 triple
helices, R = 2.7 nm;  4H: ∼3–5 triple helices, R = 4.0 nm; A: small aggregate R = 5.7 nm;
s:  solvent (right-most peak).
100 L 2 M NaOH was  added to each well and absorbance at 405 nm
was determined using a Fluostar plate reader (BMG Labtech, Ayles-
bury, UK).
Coating of plates with biotinylated peptide was  measured
by adding peptide solutions (100 L) to a 96-well plate for
30 min–4 h. The plate was blocked using 250 L 5% BSA in
50 mM Tris buffer with 150 mM NaCl (TBS) and then washed
with BSA-free TBS. Coated peptide was  quantitated by adding
200 L of a 1:10,000 dilution of a streptavidin–horseradish perox-
idase solution (Chemicon), washing, and developing with 200 L
3,3′,5,5′-tetramethylbenzidine substrate (Thermo Scientiﬁc). The
reaction was  stopped with 50 L 2.5 M sulphuric acid, turning the
solution yellow, and absorbance was measured at 450 nm.
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. Results
.1. Gel ﬁltration analysis of CRPcys-XL
Fig. 2 shows theoretical elution proﬁles for macromolecules of
iffering Stokes Radius from a gel ﬁltration column, see Suppl.
ections 2.10 and 2.11. These depend upon the pore sizes (a) within
he column, and the axial dispersion (b) due to both inhomogene-
ty of ﬂow and the solute interaction with the column (see Section
). Using this model to deconvolute the gel ﬁltration data, solvent
ffects (s), TCEP (s), peptide monomers (m)  and triple helices (H)
ere easily ﬁtted (Figs. 3–5). However, larger molecules seen on the
lution proﬁles may  be triple helices attached end-to-end rather
han side-by-side; triple helices with attached non-helical single
hains; or may  simply be so large as to exceed the resolution of the
ethod. Therefore, we deﬁned three higher mass states as consis-
ently as possible across the data, approximating 2 triple helices
2H), 3–5 triple helices (4H), and an aggregate of 6+ triple helices
A). A ﬁnal ﬁtted peak was the approximate mass of a peptide dimer
d), observed only in Toolkit peptide studies. This “dimer” peak
ay  include some peptide helix that unwound during the column
un, resulting in peptide monomer that elutes between helical and
onomeric masses.
Fig. 3a–c shows the elution proﬁle of three CRPcys-XL prepara-
ions, following cross-linking by SPDP. This procedure may  vary,
ccasionally yielding CRPcys-XL of low potency. The preparations
elected for this study were of high (3a), acceptable (3b) and low
3c) platelet-reactivity, the latter being unsuitable for use. The con-
ribution of each molecular species and its corresponding Stokes
adius were calculated. Up to 55% of the total peptide formed
oluble helix aggregates (Fig. 3a). The amount of soluble helical
ggregate increased with potency in CRPcys-XL-induced platelet
ggregation (Suppl. Fig. 1).
.2. Oxidation of CRPcys and GPPcys during storage
As would be expected from a peptide that can bind, and there-
ore cluster, at most three GpVI molecules [30], monomeric CRPcys
cts as a weak partial agonist [1] and can therefore antagonize the
ffect of CRPcys-XL, a potent agonist at platelet GpVI. We  therefore
nvestigated the triple-helical and polymeric states of our peptides
ver time to see what degree of polymerization of CRPcys in solution
ay  be caused by oxidative disulﬁde formation.
When CRPcys was freshly dissolved in cold buffer from freeze-
ried stock, gel ﬁltration showed that 78% of the peptide was
riple-helical, with 14% being monomeric and ∼8% being in poly-
ers of 2–4 triple helices (Fig. 4a). Over 14 d at 4 ◦C, re-folding
educed the monomer content to 9%, while oxidation increased
olymers of triple-helices to 14% (Fig. 4b). Freezing the solution
mmediately after dissolving the peptide kept it mostly reduced:
eptide monomer was 11% and helical polymers 16% after 80
 (data not shown). However, when the peptide was stored for
ong periods at 4 ◦C or was  repeatedly freeze–thawed, much more
xtensive oxidation occurred, shown in Fig. 4c–e. These polymers,
owever, still have smaller Stokes Radius compared to CRPcys-XL
ue to the different cross-linking mechanism. Repeating this exper-
ment with peptide GPPcys in N2-saturated solution resulted in
egligible oxidation over 14 d. Likewise, investigating short (1–14
) and long-term (18 month) storage of GPPcys in air-saturated
uffer gave very similar results to those obtained for CRPcys (data
ot shown)..3. Oxidation of Toolkit peptide III-24 during storage
We used a TCEP-reduced sample of III-24 to establish the elution
ime of its triple-helix (Fig. 5a). The non-reduced control (Fig. 5b)s 36 (2012) 86–93
showed an additional feature, a minor peak corresponding to a
disulﬁde-linked peptide dimer (labeled d). Non-reduced solutions
equilibrated at 4 ◦C for 12 h or longer (Fig. 5c) contained signiﬁ-
cantly less monomeric peptide (labeled m)  than the TCEP-reduced
sample. As peptide was  ﬂash-frozen from a room temperature solu-
tion before freeze-drying for storage, the re-dissolved peptide in
Fig. 5b reﬂects the initial room-temperature equilibrium composi-
tion, with more monomer. Monomer content falls over 14 d at 4 ◦C
(Fig. 5c), partly due to peptide oxidation and increased dimer con-
tent, but mainly due to folding as triple helices (as in Fig. 4a and b),
resulting in more 2- and 4-helix polymers (12% in total).
More oxidation was  caused by freeze–thawing 10 times over
14 d at −20 ◦C (Fig. 5d), or leaving the peptide at −20 ◦C over 80
d (Fig. 5e), or leaving the peptide at 4 ◦C for 37 months (Fig. 5f).
Storing peptide III 24 in N2-saturated solution with repeated
freeze–thawing over 14 d slowed oxidation four-fold (data not
shown).
Long-term storage of other Toolkit peptides resulted in variable
polymerization. Just 12% of 37 month-old III-04 had formed helical
polymers while 44% of 41-month old II-56 was  polymeric, similar
to the level shown for III-24 in Fig. 5f.
3.4. Oxidative cross-linking stabilizes the helix
A sample of III-24 (Tm 51 ◦C at 2.5 mg  mL−1) stored for 48 months
at 4 ◦C was 47% triple-helical when analyzed by gel ﬁltration at
40 ◦C. However, after 10 min  reduction with 2 mM TCEP, the pro-
portion of triple-helical peptide was 18%. Helicity was  ∼75% if gel
ﬁltration was run at 10 ◦C, regardless of the presence of TCEP.
3.5. Component analysis of oxidized peptide mixtures
Peptides were heat-denatured after storage at 4 ◦C for 9 months
or longer. They were analyzed by gel ﬁltration at 60 ◦C, and by
MALDI and electrospray mass spectrometry immediately after
heating to 60 ◦C. Their cysteine thiol content was determined using
Ellman’s reagent. This allowed us to characterize the peptide poly-
mer  mixture (Suppl. Figs. S2–S5, Tables S1 and S2, Sections 3.8,
4.4, 4.5). Brieﬂy, >90% of cysteine in peptides aged for 9 months or
more is oxidized, and cross-linked such that 5–13% of the peptide
is monomeric (mostly cyclic), 7–50% is dimeric, correlating with
peptide stability and purity, where CRPcys has less dimer than the
other peptides, and the remainder is polymeric. Positive controls
using fresh peptide were ∼95% reduced as expected.
3.6. Dynamic light scattering (DLS) of a Toolkit peptide
Gel ﬁltration revealed that, in the presence of 2 mM TCEP, pep-
tide III-24 at 2.5 mg  mL−1 was  almost free of any component bigger
than a single helix, no matter what temperature (4–50 ◦C) was
maintained before loading onto the column (see, for example,
Fig. 5a). To conﬁrm this, we undertook DLS experiments under
reducing conditions in neutral buffer. There was no evidence of any
species larger than around 16.5 kDa, equivalent to a single helix. We
could not resolve peptide monomer from helix, so mass and Stokes
Radius shown in Table 2 represent average values, decreasing with
increasing temperature due to helix denaturation. Stokes Radius
correlated well with values obtained from gel ﬁltration, and are as
expected for rod-like molecules of this mass.
3.7. Adhesion assays using cysteine- and non-cysteine-containing
peptidesWe  evaluated the coating of biotinylated peptides with or with-
out cysteine to 96-well plates, detected as described in Section
2. We could detect coating of the plastic by cysteine-containing
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Table  2
DLS data for peptide III-24 treated with 10 mM TCEP. At 50 ◦C, DLS is not stable, and
the % intensity data is not reliable. The Stokes Radius “R” is used to calculate the
molecular weight.
T (◦C) R (nm) MW (kDa) Intensity (%)
4 2.7 12 90
10 3.2  16 95
20  2.9 14 92
30  2.5 11 88
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iotinylated peptide (B-GFOGERcys), but biotinylated peptides lack-
ng cysteine-adhered poorly (B-GFOGER) or not at all (B-CRP)
Fig. 6a). Additionally, all peptides containing motifs that bind
ntegrin 21 or GpVI and terminal cysteine supported platelet
dhesion (CRPcys, GFOGERcys, B-GFOGERcys, Fig. 6b). The negative
ontrol, GPPcys, showed that (GPO)n and not (GPP)n was required for
ouse platelet adhesion, as anticipated [11]. Likewise, no platelet
dhesion was detected using other negative control peptides,
ontaining GpVI- or integrin-binding sequences but not termi-
al cysteine. Lastly, comparison of platelets from wild-type and
cR−/− knockout mice, which lack GpVI [6],  conﬁrm that platelet
dhesion to CRP is mediated by GpVI interacting with (GPO)n
nd not via some unsuspected interaction with terminal cysteine
esidues. This forces us to conclude that cysteine is required for
ethering the peptide to the plate.
Finally, using whole blood perfusion experiments [22], we
bserved thrombus formation upon GFOGERcys and CRPcys-
repared surfaces, but not upon GFOGER and CRP-prepared
urfaces (Fig. 7), where the latter peptides lack cysteine. This was
he case regardless of whether the slide had been pre-washed with
ig. 6. Adhesion experiments. (a) Streptavidin binding to coated peptide. Data for
:10,000 streptavidin dilution is shown: similar results were obtained at 1:3000 and
:1000 dilutions. (b) Wild type and FcR-gamma knockout mice platelet adhesion to
mmulon-2B 96-well plates treated with various biotinylated and non-biotinylated
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acid or alkali, although washing the surface with sodium hydroxide
prior to coating led to the deposition of noticeably larger thrombi.
4. Discussion
4.1. Advantages of cysteine-containing peptides
Inclusion of cysteine in collagenous peptides offers the pos-
sibility of cross-linking, an important property exempliﬁed by
CRPcys-XL, a potent platelet agonist, whereas monomeric CRP is
an antagonist or at best a partial agonist [18]. Polymerization of the
peptide by deliberate, random cross-linking using SPDP introduces
higher-order structure into the peptide, which can only then sup-
port the clustering of GpVI which leads to activatory signaling in
platelets. This parallels the behavior of collagen itself, where ﬁbril-
lar but not monomeric collagen preparations can activate platelets.
The active peptide aggregate within CRPcys-XL can be calculated to
have an average Stokes Radius of 8.6 nm from its elution volume
(Fig. 3). This is similar to the 8.9 nm Stokes Radius of the rod-like
86 kDa glycoprotein, extensin [32], which has the mass and length
of ∼8 CRPcys triple helices. Therefore, the active CRPcys-XL aggre-
gate must contain at least 8, and probably many more, CRPcys triple
helices, as the peptide helices are unlikely to align lengthwise [8].
The elution volume from gel ﬁltration of CRPcys also showed that a
single CRPcys helix at 10 ◦C has a Stokes’ Radius of ∼2 nm (its length
being 11 nm). As the molecular mass varies with the cube of the
Stokes Radius, we can estimate that a CRPcys-XL aggregate contains
up to 80 CRPcys triple helices.
A second valuable property of terminal cysteine residues in pep-
tides is that they enhanced the adhesion of the peptide to plastics
(Fig. 6a), glass (Fig. 7), and gold [26] without further modiﬁca-
tion. This may  be a speciﬁc property of cysteine sidechains, or may
result from multiple, co-operative, weak interactions that become
possible with oxidized polymeric peptides. Using peptides lack-
ing cysteine may  mean that binding sites remain undiscovered as
both peptide and target protein may  be washed off surfaces. It is
also likely that less peptide will be needed for surface coating. Of
note, while B-GFOGER adhered to plastic poorly compared to B-
GFOGERcys, it adhered better than B-CRP (Fig. 6a). We  speculate that
the GFOGER sidechains may  improve the limited peptide adhesion.
Third, light-scattering experiments under reducing conditions
conﬁrmed that III-24 denatures to single chains at temperatures
of 50 ◦C or higher (Table 2), and gel ﬁltration showed that cross-
linking resulting from chance oxidation can stabilize the triple
helices. Stabilization alternatively could be achieved either by
replacing the (GPP)5 host sequence on either side of the guest
sequence with a more stable (GPO)5 host sequence, or by length-
ening the peptide. However, the former means that every peptide
could be recognized by GpVI, LAIR, and possibly other proteins [23],
complicating analysis, while the latter not only increases the dif-
ﬁculty and expense of the synthesis, but is likely to reduce the
solubility of the peptide.
Fourth, we have been able to separate various sizes of triple-
helical cross-linked fractions from a gel ﬁltration column, and it
would be possible to assay them individually for binding activ-
ity. Because they are stable enough to remain in one state for the
duration of a column run at 10 ◦C, they will at least be useful for
experiments under cold conditions. Previous work has suggested
that the half-life of any one folded helix is at least a few hours
provided it is more than 20 ◦C below its melting temperature [27].
Finally, we  have shown that most of the peptide monomer
present in a sample becomes oxidized when stored for a long time
at 4 ◦C (Suppl. Sections 3.8–3.11), and therefore cyclic. Gel ﬁltration
can be used to isolate cyclic peptide as a potentially useful control
material which cannot form triple helices.
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FOGER (see Section 2). Peptides without cysteine did not support platelet binding
.2. Oxidation of peptides during storage and handling
Multiple freeze–thawing while storing at −20 ◦C resulted in
onsiderably faster oxidation over the same period of both III-
4 and CRPcys compared to simply storing the peptide at 4 ◦C
Figs. 4e and 5d). This effect meant that peptide frozen for as much
s 80 d and then thawed could have an oxidation proﬁle similar to
 sample stored for much longer at 4 ◦C (Fig. 5).
Storage over longer periods at 4 ◦C (9+ months), with occasional
se, caused all peptides to oxidize almost to completion (Suppl.
ection 3.10). After denaturation of peptide triple helices, analysis
f these peptides showed that CRPcys had formed larger peptide
olymers than GPPcys (Suppl. Section 3.9), and this was reﬂected in
t forming larger aggregates. While this may  be because the CRPcys
orms more stable triple helices, the data from Toolkit peptides
uggested otherwise, where lower stability III-24 had formed both
arger peptide polymers than III-04 over time (Tables S1 and S2),
nd these also resulted in larger helical aggregates than peptide
II-04.
.3. Disadvantages of cysteine-containing peptides
Oxidation of cysteine has been shown to be unavoidable under
ormal storage conditions (Figs. 3–5). This can be conﬁrmed arith-
etically. At a stock concentration of 1 mg  mL−1, the molarity of
hese peptides is typically 0.2–0.7 mM.  The oxygen content of air-
aturated water is 0.41 mM at 4 ◦C, reducing to 0.26 mM at 25 ◦C.
 single oxygen molecule can oxidize four cysteines to two cys-
eine cross-links, so there is at least a two-fold excess of oxygen
ver cysteine. Even if one retains stocks at 5 mg  mL−1 to reduce
his effect, the 500 L of air that is a typical headspace within an
ppendorf tube contains 4.4 mol  of oxygen at atmospheric pres-
ure. Over time, this can saturate a 5 mg  mL−1 peptide solution kept
t 4 ◦C, providing enough oxygen for complete peptide oxidation. HCl or NaOH before coating with a mixture of CRPcys and GFOGERcys or CRP and
ombus formation (scale bar = 50 M).
So, unless peptide solutions are stored under nitrogen, or ﬂash-
frozen from a nitrogen-saturated state, cysteine thiols will slowly
oxidize until they reach redox equilibrium. This will be especially
so during freeze–thawing in air, where raising the temperature to
room temperature and back to freezing causes the movement of
oxygen into and out of solution due to its differential solubility at
these temperatures, and, in addition, causes peptide concentration
to increase locally during freezing.
Second, until oxidation is complete after protracted storage,
there is no simple correlation between age and peptide oxidation
state, as cross-linking appears to be dependent on both peptide
identity and handling (Figs. 3–5,  and Suppl. Sections 3.8–3.11,
4.4–4.5).
Third, the presence of terminal cysteines makes it more likely
that the peptide will precipitate upon extended storage at high
concentrations, as a consequence of disulﬁde-mediated formation.
Visible precipitation has not occurred within 1 mg  mL−1 solutions
of Toolkit peptides stored long-term in 10 mM acetic acid at 4 ◦C,
but we  have observed precipitation of 5 mg mL−1 solutions of
Toolkit peptides at neutral pH even under reduced conditions (data
not shown). Another collagen peptide lacking cysteine has been
shown to form higher-order structures at concentrations as low
as 1.4 mg  mL−1 due to interactions involving aromatic residues [9],
so aggregation will be a co-operative effect involving cross-linking
and non-covalent interactions. Heating precipitated peptide helix
aggregates usually re-dissolves them as monomers and small
peptide polymers, and they can be cooled to allow refolding, regen-
erating at least a temporary working solution at high concentration.
Precipitation in the form of ﬁbril formation may  of course be desir-
able if a peptide is designed to form ﬁbrils [13,21], which may have
other experimental applications.
Formation of soluble micro-aggregates of peptide triple helices
by air-induced oxidative or SPDP-induced chemical cross-linking
can be reversed by adding TCEP to the solution if the subsequent
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sage is compatible with its presence or easy removal. Likewise,
ir-induced oxidation can be minimized by storage under nitro-
en; by dissolving fresh peptide from a freeze-dried stock; or by
liquotting and storing at −80 ◦C, although oxidation will still occur
uring the freeze–thawing process, and slowly while frozen (com-
are Fig. 5c and d – oxidation rates at −80 ◦C were not tested).
inally, a non-cysteine containing peptide could be synthesized if
o other method is acceptable. We  have not observed any oxi-
ation of peptide while it is stored in a freeze-dried state at
20 ◦C.
. Conclusion
We have characterized size proﬁles of cysteine-containing colla-
en peptides after either chemical cross-linking (CRPcys-XL), where
uch cross-linking allows formation of soluble aggregates (Stokes
adius 8.6 nm)  capable of activating platelets, or after air-induced
ysteine oxidation upon storage. The latter gives rise to smaller
olymers (1–6 triple helices) resulting from inter- and intra-helix
xidation of cysteine to disulphide bonds. This air-induced oxida-
ion can be slowed by careful storage and handling.
We have also shown that cysteine facilitates strong adhesion of
mall collagen peptides to plastic and to glass, a valuable aid for
urface-dependent analyses such as solid-phase adhesion assays.
upporting information
(a) Methods for gel ﬁltration analysis are in Suppl.
ections 2.9–2.13. (b) Aggregation of platelets by CRPcys-XL
s shown in Fig. S1.  (c) Peptide oxidation states are shown in
igs. S2–S5 and Tables S1 and S2.  Results are described in Suppl.
ections 3.8–3.11 and discussed in Sections 4.4 and 4.5.
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